What are the differences between Anafranil (clomipramine) and dicyclomine, including their indications, mechanisms of action, dosing regimens, and contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anafranil (Clomipramine) vs Dicyclomine: Key Differences

These are completely different medications used for entirely different conditions: Anafranil (clomipramine) is a tricyclic antidepressant primarily indicated for obsessive-compulsive disorder and depression, while dicyclomine is an antispasmodic used for irritable bowel syndrome.

Indications

Anafranil (Clomipramine):

  • Primary indication: Obsessive-compulsive disorder (OCD) 1
  • Also used for treatment-resistant depression 2
  • Effective for panic disorder 2

Dicyclomine:

  • Indicated specifically for functional bowel/irritable bowel syndrome (IBS) 3
  • Used to reduce abdominal pain and smooth muscle spasm 4

Mechanism of Action

Anafranil (Clomipramine):

  • Non-selective serotonin reuptake inhibitor (SRI) 1
  • Blocks reuptake of serotonin as primary action 5
  • Its metabolite (desmethylclomipramine) is a potent norepinephrine reuptake inhibitor 5
  • Has significant anticholinergic properties 2

Dicyclomine:

  • Anticholinergic/antimuscarinic agent 6
  • Reduces smooth muscle contraction in the gastrointestinal tract 4
  • May reduce visceral hypersensitivity 4

Dosing Regimens

Anafranil (Clomipramine):

  • For OCD: Response typically requires doses >75 mg/day 5
  • Maximum recommended daily dose: 250 mg 5
  • Time to steady-state: approximately 3 weeks due to long half-life (24h for parent drug, 96h for active metabolite) 7
  • Treatment duration: 8-12 weeks needed to determine efficacy 1
  • Maintenance: minimum 12-24 months after achieving remission 1

Dicyclomine:

  • Dosing varies by formulation and patient response 4
  • Used as needed for symptom control in IBS 4
  • Shorter duration of action compared to clomipramine

Contraindications

Anafranil (Clomipramine) - Absolute Contraindications 8:

  • Hypersensitivity to clomipramine or other tricyclic antidepressants
  • Concurrent use with MAOIs or within 14 days of MAOI discontinuation (serotonin syndrome risk)
  • Use with linezolid or IV methylene blue
  • Acute recovery period after myocardial infarction

Dicyclomine - Contraindications 3:

  • Infants <6 months of age
  • Nursing mothers
  • Unstable cardiovascular status in acute hemorrhage
  • Myasthenia gravis
  • Glaucoma
  • Obstructive uropathy
  • Obstructive gastrointestinal disease
  • Severe ulcerative colitis
  • Reflux esophagitis

Adverse Effects Profile

Anafranil (Clomipramine):

  • Predominantly anticholinergic effects (dry mouth, dizziness, blurred vision) 2
  • Urinary retention is a significant concern 9
  • Sexual dysfunction 1
  • Seizure risk: 0.48% at ≤250 mg/day, 2.1% at ≥300 mg/day 2
  • Cardiovascular effects 5
  • Gastrointestinal symptoms 1

Dicyclomine:

  • Anticholinergic effects (dry mouth, dizziness, blurred vision) 4
  • Generally mild to moderate adverse effects 4
  • No serious adverse events reported in trials 4
  • May worsen constipation due to anticholinergic effects 4

Clinical Considerations

Therapeutic monitoring for clomipramine: Blood concentrations <150 mcg/L associated with nonresponse; >450 mcg/L rarely improve efficacy. Narrow therapeutic range makes monitoring valuable 7.

Drug interactions: Clomipramine shows significant interactions with neuroleptics (especially phenothiazines), and its metabolism is affected by smoking and alcohol 7. Recent evidence shows competitive inhibition of other drug metabolism via CYP2D6 10.

Efficacy comparison within class: For OCD, clomipramine may be more efficacious than SSRIs in meta-analyses, though head-to-head trials show equivalent efficacy. SSRIs are preferred first-line due to superior safety and tolerability profile 1.

For IBS: Dicyclomine shows improvement in global IBS symptoms (RR 0.67) and abdominal pain (RR 0.74) compared to placebo, though evidence certainty is low to very low 4.

Related Questions

What is clomipramine, including its mechanism of action, clinical indications, dosing guidelines, and contraindications?
Can an adult female patient who is currently taking clomipramine 25 mg at bedtime be increased to 50 mg orally at bedtime despite experiencing sedation?
How should clomipramine be initiated, titrated, monitored, and what are its contraindications and side‑effect management?
Can clomipramine (a tricyclic antidepressant) help treat major depressive disorder?
What is the recommended dose of clomipramine?
Is a separate specialization degree required for General Practitioners in the United Kingdom, or is completion of GP specialty training and Membership of the Royal College of General Practitioners (MRCGP) sufficient?
Is long‑term fluvoxamine (50–100 mg daily) safe in a patient who has been on it for eight years with stable anxiety/OCD control, normal liver enzymes, no QT prolongation, and no interacting medications?
What are the typical presentation, pathophysiology, chief complaints, review of systems, general and systemic examination findings, primary and differential diagnoses, investigations, and management for a patient with hepatocellular carcinoma arising in cirrhosis?
Are cetirizine, paracetamol, the ofloxacin‑ornidazole combination (Cadi OR), and pancreatic enzyme preparation (PAN) safe for use while breastfeeding?
What are the differences between Camylifin (carbamazepine) and dicyclomine, including their indications, dosing, contraindications, and side effects?
Is pheniramine maleate injection safe for use in breastfeeding mothers?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.